Are withdrawal trials in paediatric rheumatic disease helpful?

[1]  R. Fernandes,et al.  The placebo response in studies of acute migraine. , 2008, The Journal of pediatrics.

[2]  J. Kremer,et al.  The role of drug and disease registries in rheumatic disease epidemiology , 2008, Current opinion in rheumatology.

[3]  T. Lehman.  The future of pediatric rheumatology: many questions remain. , 2007, Arthritis and rheumatism.

[4]  H. Genant,et al.  Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis , 2006, Annals of Internal Medicine.

[5]  M. Boers.  Abatacept in Rheumatoid Arthritis: A New Branch on the Biologics Tree , 2006, Annals of Internal Medicine.

[6]  P. Winner,et al.  Zolmitriptan Oral Tablet in Migraine Treatment: High Placebo Responses in Adolescents , 2006, Headache.

[7]  F. Wolfe,et al.  Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[8]  M. Dougados,et al.  Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. , 2005, Arthritis and rheumatism.

[9]  R. Cron.  A signal achievement in the treatment of arthritis. , 2005, Arthritis and rheumatism.

[10]  H. Zeidler,et al.  Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data. , 2005, Arthritis and rheumatism.

[11]  J. Jacobs,et al.  Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. , 2004, Arthritis and rheumatism.

[12]  J. O'dell,et al.  Treating rheumatoid arthritis early: a window of opportunity? , 2002, Arthritis and rheumatism.

[13]  S. Berney.  Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial , 2009 .

[14]  U Pichlmeier,et al.  Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial. , 2008, Arthritis and rheumatism.

[15]  P. Whorwell,et al.  Design of treatment trials for functional gastrointestinal disorders , 1999, Gut.

[16]  J. Kremer,et al.  Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis. , 1997, British journal of rheumatology.